{"organizations": [], "uuid": "68fb7a38da20fdff1d6d374b10d116169949fd73", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-teva-pharma-and-allergan-plc-enter/brief-teva-pharma-and-allergan-plc-enters-into-settlement-agreement-idUSFWN1PR0RC", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Pharma And Allergan PLC Enters Into Settlement Agreement ​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-01T21:10:00.000+02:00", "replies_count": 0, "uuid": "68fb7a38da20fdff1d6d374b10d116169949fd73"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-teva-pharma-and-allergan-plc-enter/brief-teva-pharma-and-allergan-plc-enters-into-settlement-agreement-idUSFWN1PR0RC", "ord_in_thread": 0, "title": "BRIEF-Teva Pharma And Allergan PLC Enters Into Settlement Agreement ​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-teva pharma", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "teva", "sentiment": "negative"}, {"name": "allergan plc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}, {"name": "allergan", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Allergan Plc:\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - ‍ON JANUARY 31, CO AND ALLERGAN PLC ENTERED INTO SETTLEMENT AGREEMENT AND MUTUAL RELEASES - SEC FILING ​\n* TEVA PHARMACEUTICAL INDUSTRIES SAYS AGREEMENT PROVIDES THAT ALLERGAN WILL MAKE ONE-TIME PAYMENT OF $700 MILLION TO CO - SEC FILING\n* TEVA PHARMACEUTICAL INDUSTRIES LTD - EXPECTS TO USE THIS CASH PAYMENT FOR REPAYMENT OF A PORTION OF ITS TERM LOAN DEBT.\n* TEVA PHARMACEUTICAL INDUSTRIES LTD SAYS ONE TIME $700 MILLION ‍PAYMENT IS EXPECTED DURING Q1 OF 2018​\n* TEVA PHARMACEUTICAL INDUSTRIES LTD SAYS AGREEMENT PROVIDES CO, ALLERGAN WILL JOINTLY DISMISS WORKING CAPITAL DISPUTE ARBITRATION\n* TEVA PHARMACEUTICAL - AGREEMENT PROVIDES CO, ALLERGAN TO JOINTLY DISMISS ACTUAL, POTENTIAL CLAIMS UNDER MASTER PURCHASE AGREEMENT, DATED JULY 26, 2015 Source text: ( bit.ly/2GEMzjK ) Further company coverage:\n ", "external_links": ["http://bit.ly/2GEMzjK", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T21:10:00.000+02:00", "crawled": "2018-02-02T13:07:08.000+02:00", "highlightTitle": ""}